Oseltamivir for treatment of influenza in infants less than one year: A retrospective analysis

Pediatric Infectious Disease Journal

Volumn 29, Issue 6, 2010, Pages 495-498

  Siedler, Kai ^a,b,c   Skopnik, Heino ^a  

^a Klinikum Worms   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c NONE   (Germany)

Author keywords

Fever; Infants; Influenza; Oseltamivir; Tolerability

Indexed keywords

ANTIBIOTIC AGENT; OSELTAMIVIR; ANTIVIRUS AGENT;

ANGINA PECTORIS; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; COUGHING; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEEDING DISORDER; FEMALE; FEVER; GASTROINTESTINAL SYMPTOM; HUMAN; INFANT; INFECTIOUS PNEUMONIA; INFLUENZA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MENINGITIS; OTITIS MEDIA; PARONYCHIA; PHARYNGITIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RHINITIS; SECONDARY INFECTION; SEPSIS; TREATMENT OUTCOME; VOMITING; INFLUENZA, HUMAN; TEACHING HOSPITAL;

ANTIVIRAL AGENTS; FEMALE; HOSPITALS, TEACHING; HUMANS; INFANT; INFLUENZA, HUMAN; MALE; OSELTAMIVIR; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 77953172239     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3181cc4d01     Document Type: Article

References (25)

1. Cauchemez S, Carrat F, Viboud C, et al. A Bayesian MCMC approach to study transmission of influenza: application to household longitudinal data. Stat Med. 2004;23:3469-3487.
2. Glezen WP, Taber LH, Frank AL, et al. Influenza virus infections in infants. Pediatr Infect Dis J. 1997;16:1065-1068.
3. Bourgeois FT, Valim C, Wei JC, et al. Influenza and other respiratory virus-related emergency department visits among young children. Pediatrics. 2006;118:e1- e8.
4. Poehling KA, Edwards KM, Weinberg GA, et al. The underrecognized burden of influenza in young children. N Engl J Med. 2006;355:31-40.
5. Neuzil KM, Mellen BG, Wright PF, et al. The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. N Engl J Med. 2000;342:225-231.
6. Chiu SS, Lau YL, Chan KH, et al. Influenza-related hospitalizations among children in Hong Kong. N Engl J Med. 2002;347:2097-2103.
7. Izurieta HS, Thompson WW, Kramarz P, et al. Influenza and the rates of hospitalization for respiratory disease among infants and young children. N Engl J Med. 2000;342:232-239.
8. Bhat N, Wright JG, Broder KR, et al. Influenza-associated deaths among children in the United States, 2003-2004. N Engl J Med. 2005;353:2559-2567.
9. Fiore AE, Shay DK, Broder K, et al. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008. MMWR Recomm Rep. 2008;57(RR-7):1-60.
10. Influenza vaccination coverage among children aged 6-23 months-United States, 2006-07 influenza season. MMWR Morb Mortal Wkly Rep. 2008; 57:1039-1043.
11. Jimenez-Garcia R, Hernandez-Barrera V, Carrasco-Garrido P, et al. Influenza vaccination coverages among children, adults, health care workers and immigrants in Spain: related factors and trends, 2003-2006. J Infect. 2008;57:472-480.
12. Whitley RJ, Hayden FG, Reisinger KS, et al. Oral oseltamivir treatment of influenza in children. Pediatr Infect Dis J. 2001;20:127-133.
13. Hayden FG, Belshe R, Villanueva C, et al. Management of influenza in households: a prospective, randomized comparison of oseltamivir treatment with or without postexposure prophylaxis. J Infect Dis. 2004;189:440-449.
14. European Medicines Agency (EMEA). European Medicines Agency recommends updating the product information for Tamiflu, 31 July 2009. Available at: http://www.emea.europa.eu/influenza/newsroom/newsroom. html. Accessed November12, 2009.
15. European Medicines Agency (EMEA). European Medicines Agency recommends updating Tamiflu product information, 1 October 2009. Available at: http://www.emea.europa.eu/influenza/newsroom/newsroom.html. Accessed November 12, 2009.
16. European Medicines Agency (EMEA). Oseltamivir Summary of Product Characteristics, 2009. Available at: http://www.emea.europa.eu/humandocs/ PDFs/EPAR/tamiflu/Tamiflu-PI-clean-en.pdf. Accessed November 12, 2009.
17. Centers for Disease Control and Prevention (CDC). Emergency Use Authorization of Tamiflu (oseltamivir). Available at: http://www.cdc. gov/h1n1flu/eua/tamiflu.htm. Accessed November 12, 2009.
18. United States Food and Drug Administration (FDA). Emergency dosing recommendations for treatment and prophylaxis of influenza in pediatric patients less than 1 year old. Available at: http://www.fda.gov/downloads/ Drugs/DrugSafety/InformationbyDrugClass/UCM153546.pdf. Accessed November 12, 2009.
19. Okamoto S, Kamiya I, Kishida K, Shimakawa T, Fukui T, Morimoto T. Experience with oseltamivir for infants younger than 1 year old in Japan. Pediatr Infect Dis J. 2005;24(6):575-576.
20. Tamura D, Miura T, Kikuchi Y. Oseltamivir phosphate in infants under 1 year of age with influenza infection. Pediatr Int. 2005;47:484.
21. Toovey S, Rayner C, Prinssen E, et al. Assessment of neuropsychiatric adverse events in influenza patients treated with oseltamivir: a comprehensive review. Drug Saf. 2008;31:1097-1114.
22. Morishima T, Togashi T, Yokota S, et al. Encephalitis and encephalopathy associated with an influenza epidemic in Japan. Clin Infect Dis. 2002;35: 512-517.
23. Kasai T, Togashi T, Morishima T. Encephalopathy associated with influenza epidemics. Lancet. 2000;355:1558-1559.
24. Tsolia MN, Logotheti I, Papadopoulos NG, et al. Impact of influenza infection in healthy children examined as outpatients and their families. Vaccine. 2006;24:5970-5976.
25. Belshe RB, Mendelman PM, Treanor J, et al. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children. N Engl J Med. 1998;338:1405-1412.